Dalcetrapib
- Generic Name
- Dalcetrapib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H35NO2S
- CAS Number
- 211513-37-0
- Unique Ingredient Identifier
- 3D050LIQ3H
- Background
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
- First Posted Date
- 2006-07-18
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 135
- Registration Number
- NCT00353522
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath